AAAAAA

   
Results: 1-14 |
Results: 14
INTRACISTERNAL A-PARTICLE ELEMENT TRANSPOSITION INTO THE MURINE BETA-GLUCURONIDASE GENE CORRELATES WITH LOSS OF ENZYME-ACTIVITY - A NEW MODEL FOR BETA-GLUCURONIDASE DEFICIENCY IN THE C3H MOUSE
Authors: GWYNN B LUEDERS K SANDS MS BIRKENMEIER EH
Citation: B. Gwynn et al., INTRACISTERNAL A-PARTICLE ELEMENT TRANSPOSITION INTO THE MURINE BETA-GLUCURONIDASE GENE CORRELATES WITH LOSS OF ENZYME-ACTIVITY - A NEW MODEL FOR BETA-GLUCURONIDASE DEFICIENCY IN THE C3H MOUSE, Molecular and cellular biology (Print), 18(11), 1998, pp. 6474-6481
MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII - THE IMPACT OF THERAPIES ON THE CLINICAL COURSE AND PATHOLOGY IN A MURINE MODEL OF LYSOSOMAL STORAGEDISEASE
Authors: VOGLER C SANDS MS GALVIN N LEVY B THORPE C BARKER J SLY WS
Citation: C. Vogler et al., MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII - THE IMPACT OF THERAPIES ON THE CLINICAL COURSE AND PATHOLOGY IN A MURINE MODEL OF LYSOSOMAL STORAGEDISEASE, Journal of inherited metabolic disease, 21(5), 1998, pp. 575-586
ENZYME REPLACEMENT THERAPY FOR MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII LEADS TO IMPROVEMENTS IN BEHAVIOR AND AUDITORY FUNCTION
Authors: OCONNOR LH ERWAY LC VOGLER CA SLY WS NICHOLES A GRUBB J HOLMBERG SW LEVY B SANDS MS
Citation: Lh. Oconnor et al., ENZYME REPLACEMENT THERAPY FOR MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII LEADS TO IMPROVEMENTS IN BEHAVIOR AND AUDITORY FUNCTION, The Journal of clinical investigation, 101(7), 1998, pp. 1394-1400
GENE-THERAPY FOR MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII
Authors: SANDS MS WOLFE JH BIRKENMEIER EH BARKER JE VOGLER C SLY WS OKUYAMA T FREEMAN B NICHOLES A MUZYCZKA N CHANG PL AXELROD HR
Citation: Ms. Sands et al., GENE-THERAPY FOR MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII, Neuromuscular disorders, 7(5), 1997, pp. 352-360
MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII - LONG-TERM THERAPEUTIC EFFECTSOF ENZYME REPLACEMENT AND ENZYME REPLACEMENT FOLLOWED BY BONE-MARROW TRANSPLANTATION
Authors: SANDS MS VOGLER C TORREY A LEVY B GWYNN B GRUBB J SLY WS BIRKENMEIER EH
Citation: Ms. Sands et al., MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII - LONG-TERM THERAPEUTIC EFFECTSOF ENZYME REPLACEMENT AND ENZYME REPLACEMENT FOLLOWED BY BONE-MARROW TRANSPLANTATION, The Journal of clinical investigation, 99(7), 1997, pp. 1596-1605
ENZYME REPLACEMENT WITH RECOMBINANT BETA-GLUCURONIDASE IN MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII - IMPACT OF THERAPY DURING THE FIRST 6 WEEKS OF LIFE ON SUBSEQUENT LYSOSOMAL STORAGE, GROWTH, AND SURVIVAL
Authors: VOGLER C SANDS MS LEVY B GALVIN N BIRKENMEIER EH SLY WS
Citation: C. Vogler et al., ENZYME REPLACEMENT WITH RECOMBINANT BETA-GLUCURONIDASE IN MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII - IMPACT OF THERAPY DURING THE FIRST 6 WEEKS OF LIFE ON SUBSEQUENT LYSOSOMAL STORAGE, GROWTH, AND SURVIVAL, Pediatric research, 39(6), 1996, pp. 1050-1054
HIGH-LEVEL EXPRESSION AND EXPORT OF BETA-GLUCURONIDASE FROM MURINE MUCOPOLYSACCHARIDOSIS-VII CELLS CORRECTED BY A DOUBLE-COPY RETROVIRUS VECTOR
Authors: WOLFE JH KYLE JW SANDS MS SLY WS MARKOWITZ DG PARENTE MK
Citation: Jh. Wolfe et al., HIGH-LEVEL EXPRESSION AND EXPORT OF BETA-GLUCURONIDASE FROM MURINE MUCOPOLYSACCHARIDOSIS-VII CELLS CORRECTED BY A DOUBLE-COPY RETROVIRUS VECTOR, Gene therapy, 2(1), 1995, pp. 70-78
SYNGENEIC BONE-MARROW TRANSPLANTATION REDUCES THE HEARING-LOSS ASSOCIATED WITH MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII
Authors: SANDS MS ERWAY LC VOGLER C SLY WS BIRKENMEIER EH
Citation: Ms. Sands et al., SYNGENEIC BONE-MARROW TRANSPLANTATION REDUCES THE HEARING-LOSS ASSOCIATED WITH MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII, Blood, 86(5), 1995, pp. 2033-2040
ENZYME REPLACEMENT WITH RECOMBINANT BETA-GLUCURONIDASE DRAMATICALLY REDUCES LYSOSOMAL STORAGE IN THE CNS OF MICE WITH MUCOPOLYSACCHARIDOSISTYPE-VII
Authors: SANDS MS VOGLER CA GRUBB J HIGGINS A TORREY A LEVY B SLY WS BIRKENMEIER EH
Citation: Ms. Sands et al., ENZYME REPLACEMENT WITH RECOMBINANT BETA-GLUCURONIDASE DRAMATICALLY REDUCES LYSOSOMAL STORAGE IN THE CNS OF MICE WITH MUCOPOLYSACCHARIDOSISTYPE-VII, Journal of cellular biochemistry, 1994, pp. 246-246
BEHAVIORAL CONSEQUENCES OF BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII
Authors: BASTEDO L SANDS MS LAMBERT DT PISA MA BIRKENMEIER E CHANG PL
Citation: L. Bastedo et al., BEHAVIORAL CONSEQUENCES OF BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII, The Journal of clinical investigation, 94(3), 1994, pp. 1180-1186
ENZYME REPLACEMENT THERAPY FOR MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII
Authors: SANDS MS VOGLER C KYLE JW GRUBB JH LEVY B GALVIN N SLY WS BIRKENMEIER EH
Citation: Ms. Sands et al., ENZYME REPLACEMENT THERAPY FOR MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII, The Journal of clinical investigation, 93(6), 1994, pp. 2324-2331
A SINGLE-BASE-PAIR DELETION IN THE BETA-GLUCURONIDASE GENE ACCOUNTS FOR THE PHENOTYPE OF MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII
Authors: SANDS MS BIRKENMEIER EH
Citation: Ms. Sands et Eh. Birkenmeier, A SINGLE-BASE-PAIR DELETION IN THE BETA-GLUCURONIDASE GENE ACCOUNTS FOR THE PHENOTYPE OF MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII, Proceedings of the National Academy of Sciences of the United Statesof America, 90(14), 1993, pp. 6567-6571
TREATMENT OF MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII BY SYNGENEIC BONE-MARROW TRANSPLANTATION IN NEONATES
Authors: SANDS MS BARKER JE VOGLER C LEVY B GWYNN B GALVIN N SLY WS BIRKENMEIER E
Citation: Ms. Sands et al., TREATMENT OF MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII BY SYNGENEIC BONE-MARROW TRANSPLANTATION IN NEONATES, Laboratory investigation, 68(6), 1993, pp. 676-686
EFFECT OF BONE-MARROW TRANSPLANT OF THE BEHAVIORAL ABNORMALITIES OF AMURINE MODEL OF MUCOPOLYSACCHARIDOSIS TYPE-VII (SLY DISEASE)
Authors: KHIMANI L SANDS MS BIRKENMEIER EH PISA MA CHANG PL
Citation: L. Khimani et al., EFFECT OF BONE-MARROW TRANSPLANT OF THE BEHAVIORAL ABNORMALITIES OF AMURINE MODEL OF MUCOPOLYSACCHARIDOSIS TYPE-VII (SLY DISEASE), American journal of human genetics, 53(3), 1993, pp. 912-912
Risultati: 1-14 |